About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? feedback@clareohealth.com

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Clinical Trials in Austin | 7,637 Studies Near You

Clinical TrialsAustin

Clinical Trials in Austin

Discover 7,637 clinical trials near Austin, Texas. Find research studies in your area.

Browse by condition:

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma Pancreatic Cancer

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 4161-4180 of 7,637 trials

CompletedEfficacy and Safety of Faster-acting Insulin Aspart Compared to NovoRapid® Both in Combination With Insulin Degludec in Adults With Type 1 DiabetesThis trial is conducted in Asia, Europe and North America.NCT02500706·Tucson, Arizona and 151 others

Find Trials by Condition in Austin

Breast Cancerin Austin Lung Cancerin Austin Prostate Cancerin Austin Colorectal Cancerin Austin Melanomain Austin Leukemiain Austin Lymphomain Austin Pancreatic Cancerin Austin Ovarian Cancerin Austin Brain Cancerin Austin Diabetesin Austin

Data from ClinicalTrials.govTerms

UnknownTreatment Of Atrial Fibrillation In Preserved Cardiac Function Heart FailureHeart failure (HF) with preserved left ventricular function (pEF) is difficult clinical syndrome to treat effectively with few evidence based therapies.NCT04160000·Flagstaff, Arizona and 8 others

TerminatedStudy of Safety and Efficacy of Brolucizumab 6 mg Dosed Every 4 Weeks Compared to Aflibercept 2 mg Dosed Every 4 Weeks in Patients With Retinal Fluid Despite Frequent Anti-VEGF InjectionsThis clinical study was designed to compare the safety and efficacy of brolucizumab 6 mg dosed every 4 weeks to aflibercept 2 mg dosed every 4 weeks in those neovascular…NCT03710564·Phoenix, Arizona and 60 others

RecruitingCNP-103 in Adolescent and Adult Subjects Ages 12-35 With Recently Diagnosed (Within 6 Months) Stage 3 Type 1 Diabetes (T1D)This study is a Phase 1b/2a First-in-Human (FIH) clinical trial to assess the safety, tolerability, pharmacodynamics (PD), and efficacy of multiple ascending doses of CNP-103.NCT06783309·Tucson, Arizona and 44 others

CompletedBCI-controlled NMES in Subacute StrokeStroke patients with severe upper limb movement deficits have limited treatment options and often remain severely handicapped at the chronic stage.NCT03379532·Austin, Texas and 1 other

RecruitingPhase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive SubjectsThis is a prospective, randomized, double-blinded, placebo-controlled, multi-center, Phase 3 study of GLSI-100 immunotherapy in HLA-A\*02 positive and HER2/neu positive subjects…NCT05232916·Mobile, Alabama and 178 others

CompletedSafety and Immunogenicity of AdCOVID in Healthy Adults (COVID-19 Vaccine Study)A study to evaluate the immune response and safety of AdCOVID administered as an intranasal spray in healthy adults.NCT04679909·Hialeah, Florida and 5 others

Active not recruitingA Study to Compare Darolutamide Given With Androgen Deprivation Therapy (ADT) and Placebo Given With ADT in Men With Hormone Sensitive Prostate Cancer and Raise of Prostate Specific Antigen (PSA) Levels After Local TherapiesResearchers are looking for a better way to treat men at high-risk of biochemical recurrence (BCR) of prostate cancer.NCT05794906·Phoenix, Arizona and 225 others

CompletedA Study Assessing the Safety and Efficacy of DE-117 Ophthalmic Solution in Patients With POAG or OHTThe purpose of this study is to investigate the safety and efficacy of up to three concentrations of DE-117 ophthalmic solution (Low Dose, Medium Dose, and High Dose) as…NCT01654484·Newport Beach, California and 9 others

UnknownEvaluating the Safety, Tolerability and Preliminary Efficacy of Plasma in Improving the Appearance of OnychomycosisThe purpose of this study is to evaluate the safety and preliminary efficacy of using electrical plasma to treat toenail fungus.NCT02724384·Quincy, Massachusetts and 6 others

CompletedLonger-term Study of AR101 in Subjects Who Participated in a Prior AR101 Study (ARC008)The purpose of this study is to assess AR101's safety, tolerability and efficacy over an extended dosing period.NCT03292484·Birmingham, Alabama and 92 others

Active not recruitingA Study of a New Drug, Nirogacestat, for Treating Desmoid Tumors That Cannot be Removed by SurgeryThis phase II trial studies the side effects and how well nirogacestat works in treating patients less than 18 years of age with desmoid tumors that has grown after at least one…NCT04195399·Birmingham, Alabama and 97 others

UnknownDual Targeting of Vascular Endothelial Growth Factor-A Together With Angiopoietins in Chemotherapy-naïve Metastatic Colorectal CancerThis is a clinical trial investigating the effectiveness and safety of the combination of the study drugs bevacizumab and AMG386 in patients with advanced (metastatic)…NCT01249521·Melbourne, Victoria

CompletedEvaluation of Vitrectomy for Diabetic Macular EdemaThe study is designed as a prospective cohort study to assess changes in visual acuity and retinal thickening and surgical complications in subjects undergoing vitrectomy for…NCT00709319·Irvine, California and 47 others

CompletedStudy to Explore the Efficacy and Safety of BIO89-100 (Pegozafermin) in Participants With Severe HypertriglyceridemiaThis study is designed to assess the efficacy, safety, and tolerability of different doses and dose regimens (once weekly \[QW\] or every 2 weeks \[Q2W\]), subcutaneous (SC)…NCT04541186·La Mesa, California and 47 others

CompletedStudy to Evaluate the Relative Bioavailability of Two Risankizumab Drug Product Presentations in Healthy Volunteers.This study will assess how safe risankizumab is and how risankizumab moves through the body of adult healthy participants. Adverse Events will be assessed.NCT05567029·Anaheim, California and 4 others

TerminatedPhase 2 Study of Poziotinib in Participants With NSCLC Having EGFR or HER2 Exon 20 Insertion MutationThis is a Phase 2, open-label, multi-center study to evaluate the efficacy and the safety/tolerability of poziotinib in seven participant cohorts for up to 603 previously treated…NCT03318939·Phoenix, Arizona and 62 others

RecruitingA Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants With Macular Edema Secondary to Inflammation (MESI) - PINNACLEA Phase 3 Study to Evaluate the Efficacy and Safety of Intravitreal KSI-101 in Participants with Macular Edema Secondary to Inflammation (MESI)NCT06996080·Phoenix, Arizona and 55 others

CompletedA Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque PsoriasisThe purpose of the study is to evaluate pharmacokinetic similarity, efficacy, safety and immunogenicity of multiple switches between ustekinumab and ABP 654 compared with…NCT04761627·Hot Springs, Arkansas and 87 others

CompletedA Trial Comparing the Efficacy and Safety of Insulin Degludec/Liraglutide and Insulin Degludec in Subjects With Type 2 DiabetesThis trial is conducted in Asia, Europe and the United States of America (USA).NCT01392573·Huntsville, Alabama and 85 others

PreviousPage 209 of 382Next

Heart Diseasein Austin